Asset Manager

Updated:

Jihua Brilliant Investment

Jihua Brilliant Investment translates R&D from Foshan's Jihua Laboratory into equity in deep-tech spinouts across optics, semiconductors, and robotics.

Jihua Brilliant Investment

Jihua Brilliant Investment is a Foshan, China-based investment company focused on the Asia region.

General information

Firm type

Generalist

Year founded

2023

Location

Region

Asia

Country

China

City

Foshan

Corporate office

Foshan, Guangdong, China

Sector focus

Industrial TechAI/MLEnergy Transition & Renewables

Frequently asked questions

What is the relationship between Jihua Brilliant Investment and Jihua Laboratory?

Jihua Brilliant Investment functions as the commercial investment vehicle for Jihua Laboratory, a provincial-level research institute in Foshan focused on advanced manufacturing. It originates its deal flow almost exclusively from technologies and teams incubated within the laboratory's research programs. The arrangement allows the laboratory to retain equity in its spinouts rather than relying solely on licensing income. The firm's investment team operates in close coordination with the laboratory's technology transfer and research leadership.

Who are Jihua Brilliant's typical co-investors?

Jihua Brilliant frequently co-invests alongside domain-focused Chinese venture funds and provincial industrial funds that operate within Guangdong's manufacturing and semiconductor ecosystem. One documented co-investor is Xindongneng Investment, which specializes in semiconductor and optoelectronics deals. The firm's rounds often include other public-private partnership vehicles aligned with Pearl River Delta industrial development priorities.

Where does Jihua Brilliant source its deals?

The firm sources its deals almost exclusively from within Jihua Laboratory itself, which employs over 1,400 researchers across disciplines including optics, materials science, and robotics. This internal pipeline means the firm does not compete in broadly auctioned venture rounds or rely on traditional venture syndicate introductions. Its deal volume is therefore a direct function of the laboratory's research output and spinout readiness rather than market conditions.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Foshan Generalist profiles